This report studies the global Preclinical Imaging market status and forecast, categorizes the global Preclinical Imaging market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, India, Southeast Asia and other regions (Central & South America, and Middle East & Africa). Preclinical imaging is the visualization of living animals for research purposes, such as drug development. Imaging modalities have long been crucial to the researcher in observing changes, either at the organ, tissue, cell, or molecular level, in animals responding to physiological or environmental changes. Imaging modalities that are non-invasive and in vivo have become especially important to study animal models longitudinally. Broadly speaking, these imaging systems can be categorized into primarily morphological/anatomical and primarily molecular imaging techniques. Techniques such as high-frequency micro-ultrasound, magnetic resonance imaging (MRI) and computed tomography (CT) are usually used for anatomical imaging, while optical imaging (fluorescence and bioluminescence), positron emission tomography (PET), and single photon emission computed tomography (SPECT) are usually used for molecular visualizations. In 2018, the global preclinical imaging market is expected to be dominated by North America. A number of factors such as robust R&D infrastructure for life science researches, fast adoption of novel molecular imaging technologies, significant presence of pharmaceutical and biotechnology companies, and increasing preference of end users for multimodality systems are driving the growth of the preclinical imaging market in the North American region. The Asia-Pacific market is expected to grow at the highest CAGR from 2018 to 2023. This is primarily due to the continuous government support for pharmaceutical and biotechnology R&D, increasing public-private investments to support radioisotope production, rising number of translational research activities, and evolving regulatory scenario across major Asian countries. The global Preclinical Imaging market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025. The major manufacturers covered in this report Perkinelmer Bruker Fujifilm Mediso Milabs MR Solutions Aspect Imaging Li-Cor Biosciences Trifoil Imaging Miltenyi Biotec Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering North America Europe China Japan India Southeast Asia Other regions (Central & South America, Middle East & Africa) We can also provide the customized separate regional or country-level reports, for the following regions: North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Rest of Asia-Pacific Europe Germany France UK Italy Spain Russia Rest of Europe Central & South America Brazil Argentina Rest of South America Middle East & Africa Saudi Arabia Turkey Rest of Middle East & Africa On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Optical Imaging Systems Nuclear Imaging Systems Micro-MRI Systems Micro-Ultrasound Systems Micro-CT Systems Preclinical Photoacoustic Imaging Systems Preclinical Magnetic Particle Imaging (MPI) Systems By Application, the market can be split into Hospital Diagnostics Center Others The study objectives of this report are: To analyze and study the global Preclinical Imaging capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025); Focuses on the key Preclinical Imaging manufacturers, to study the capacity, production, value, market share and development plans in future. Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis. To define, describe and forecast the market by type, application and region. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. To identify significant trends and factors driving or inhibiting the market growth. To analyze the opportunities in the market for stakeholders by identifying the high growth segments. To strategically analyze each submarket with respect to individual growth trend and their contribution to the market. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. To strategically profile the key players and comprehensively analyze their growth strategies. In this study, the years considered to estimate the market size of Preclinical Imaging are as follows: History Year: 2013-2017 Base Year: 2017 Estimated Year: 2018 Forecast Year 2018 to 2025 For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered. Key Stakeholders Preclinical Imaging Manufacturers Preclinical Imaging Distributors/Traders/Wholesalers Preclinical Imaging Subcomponent Manufacturers Industry Association Downstream Vendors Available Customizations With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report: Regional and country-level analysis of the Preclinical Imaging market, by end-use. Detailed analysis and profiles of additional market players.
Table of Contents Global Preclinical Imaging Market Professional Survey Report 2018 1 Industry Overview of Preclinical Imaging 1.1 Definition and Specifications of Preclinical Imaging 1.1.1 Definition of Preclinical Imaging 1.1.2 Specifications of Preclinical Imaging 1.2 Classification of Preclinical Imaging 1.2.1 Optical Imaging Systems 1.2.2 Nucl
